Cited 0 times in
Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06).
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.